HOPEWELL THERAPEUTICS INC.
Synthetic Lipid-based drug delivery company
Hopewell Therapeutics Inc. is developing novel synthetic lipid based nanoparticles for nucleic acid delivery for gene therapy and gene editing. The technology is licensed from Tufts University. We have identified LNPs that can deliver cargos in organ and cell specific manner. Our mission is to provide cutting-edge technology and services in the field
of novel drug delivery systems.
WHAT WE DO
Drug delivery, Drug formulation, Biomacromolecule based drug discovery